GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4435)

  • GC91375 structure
    GC91375Promethazine Sulfoxide
    CAS: 7640-51-9
    Purity: >95.00%

    Le sulfoxyde de prométhazine est un métabolite de l'antagoniste du récepteur H1 de l'histamine, la prométhazine.

  • GC91379 structure
    GC91379BDW568
    CAS: 335401-44-0
    Purity: >98.00%

    BDW568 est un agoniste du stimulateur des gènes de l'interféron (STING) et une forme de prodrogue de BDW-OH.

  • GC91380 structure
    GC91380N6F11
    CAS: 851398-76-0
    Purity: >99.50%

    N6F11 est un inducteur de la ferroptose.

  • GC91389 structure
    GC91389J27644
    Purity: >95.00%

    J27644 est un inhibiteur de l'histone désacétylase 6 (HDAC6 ; IC50 = 10 nM).

  • GC91397 structure
    GC91397N-desmethyl Levofloxacin (hydrochloride)
    Purity: >98.00%

    N-déméthyl Lévofloxacine est un métabolite actif de l'antibiotique fluoroquinolone lévofloxacine.

  • GC91406 structure
    GC91406UK 122 (trifluoroacetate salt)
    CAS: 1186653-73-5
    Purity: >95.00%

    Le UK 122 est un inhibiteur de l'activateur de plasminogène de type urokinase (uPA ; IC50 = 0,2 µM).

  • GC91424 structure
    GC91424S1PL-IN-31
    CAS: 1538574-95-6
    Purity: >98.00%

    S1PL-IN-31 est un inhibiteur de la lyase de sphingosine-1-phosphate (S1P) (IC50 = 210 nM).

  • GC91449 structure
    GC91449Ipamorelin (acetate)
    Purity: >98.00%

    Ipamorelin est un agoniste du récepteur GHS 1a (GHS-R1a) et un sécrétagogue d'hormone de croissance pentapeptide (GHS).

  • GC91590 structure
    GC91590DTPD-Q
    CAS: 252950-56-4
    Purity: >98.00%

    DTPD-Q is an oxidized derivative of the antioxidant and methylphenyl substituted p-phenylenediamine DTPD.

  • GC91595 structure
    GC91595PDIC-NC
    CAS: 2633013-75-7
    Purity: >95.00%

    PDIC-NC is an activator of stimulator of interferon genes (STING) and an anticancer agent.

  • GC91598 structure
    GC91598GPX4 16
    CAS: 2644044-43-7
    Purity: >98.00%

    GPX4 16 is an inhibitor of glutathione peroxidase 4 (GPX4).

  • GC91612 structure
    GC91612FDW028
    CAS: 2768426-49-7
    Purity: >98.00%

    FDW028 is an inhibitor of fucosyltransferase 8 (FUC8).

  • GC91623 structure
    GC91623Ferroptosis Inducer 24
    CAS: 28657-88-7
    Purity: >95.00%

    Ferroptosis inducer 24 is an inducer of ferroptosis.

  • GC91659 structure
    GC91659BDW-OH
    CAS: 573976-22-4
    Purity: >95.00%

    BDW-OH is an active metabolite of the STING agonist and prodrug BDW568 .

  • GC91670 structure
    GC91670MRSA Antibiotic 1
    CAS: 667410-81-3
    Purity: >95.00%

    MRSA antibiotic 1 is an antibiotic.

  • GC91673 structure
    GC91673CPPD-Q
    CAS: 68054-78-4
    Purity: >98.00%

    CPPD-Q est un dérivé oxydé de l'antioxydant CPPD. Il possède des effets antibactériens et insecticides.

  • GC91680 structure
    GC916804-Acetamido Antipyrine
    CAS: 83-15-8
    Purity: >95.00%

    4-Acetamido antipyrine (4-AAAP) is an active metabolite of the non-opioid analgesic and antipyretic prodrug metamizole .

  • GC91681 structure
    GC91681Loxoprofen-SRS
    CAS: 83648-76-4
    Purity: >98.00%

    Loxoprofen-SRS is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.5 and 0.39 for recombinant human COX-1 and COX-2, respectively) and an active metabolite of the prodrug loxoprofen .

  • GC91688 structure
    GC91688PDIC-NN
    CAS: 932740-48-2
    Purity: >95.00%

    PDIC-NN is an intermediate in the synthesis of PDIC-NS , an activator of stimulator of interferon genes (STING) with anticancer activity.

  • GC91690 structure
    GC91690TASP0277308
    CAS: 945725-50-8
    Purity: >98.00%

    TASP0277308 is a sphingosine-1-phosphate receptor 1 (S1P1) antagonist (IC50 = 4.2 nM).

  • GC91768 structure
    GC91768GSK205 (hydrobromide)
    Purity: >95.00%

    GSK205 is an inhibitor of transient receptor potential vanilloid 4 (TRPV4) and transient receptor potential ankyrin 1 (TRPA1; IC50s = 4.19 and 5.56 µM, respectively, for the rat channels).

  • GC91776 structure
    GC91776PD-1/PD-L1 Inhibitor N11
    Purity: >95.00%

    PD-1/PD-L1 inhibitor N11 is an inhibitor of the protein-protein interaction between programmed cell death protein 1 (PD-1) and PD-1 ligand (PD-L1; IC50 = 6.3 nM).

  • GC91777 structure
    GC91777NVS-STG2
    Purity: >98.00%

    NVS-STG2 is an agonist of stimulator of interferon genes (STING).

  • GC91783 structure
    GC91783FA16
    Purity: >95.00%

    FA16 is a ferroptosis inducer and an inhibitor of the system xc- cystine/glutamate transporter.